Spyryx Bioscience
Spyryx Biosciences is a biopharmaceutical company based in Durham, NC, focused on developing innovative therapeutics for obstructive lung diseases, particularly Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD). Founded in 2013 by Dr. Robert Tarran, the company leverages a novel mechanism discovered in his research to restore fluid balance in the lungs, aiming to improve lung function and overall quality of life for patients.
The company's lead investigational product is an inhaled peptide designed to enhance airway hydration and mucus clearance in CF patients, regardless of their genetic mutations. Currently, Spyryx is conducting clinical trials to evaluate the efficacy and safety of this treatment, demonstrating a commitment to addressing the real-world challenges faced by individuals living with these debilitating diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.